Teva- Pharmaceutical Industries Ltd. - ADR (TEVA) stock price prediction is 15.053617 USD. The consensus among Wall Street equities research analysts is that investors should "hold" Teva Pharmaceutical Industries stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in TEVA, but not buy additional shares or sell existing shares. Teva Pharmaceutical Industries Ltd is a Israeli-based pharmaceutical company. TEVA 1.01. What is Teva Pharmaceutical stock price? Make stock comparison and analysis on (539680 | ) with TEVA PHARMACEUTICAL INDUSTRIES LTD., Israel online at Equitymaster. Free Instant Analysis. PEG Ratios below 1 indicate that a company could be undervalued. Found inside – Page 1861Fundamental Analysis of factors like earnings growth , valuation and liquidation figures supports the stock selection ... PLC 3 ) CHINA MOBILE 4 ) TELEFONOS DE MEXICO 5 ) PETROLEO BRASILEIRO 6 ) TEVA PHARMACEUTICAL INDS . Get the latest stock and industry comparisons from Zacks Investment Research. TEVA stock trades near $10 currently and it is, in fact, down 28% from its pre-Covid high of around $13 in Feb... 2 days ago - Forbes Warren Buffett's 6 Worst-Performing Stocks in Q2 Looking for insights on Teva-pharma (NYSE:TEVA) stock? $9.83. As a leading global pharmaceutical company, Teva provides essential medicines to millions of patients around the world every day. In this Wicked Signal video-analysis on Teva Pharmaceuticals (TEVA), Cary walks you through the charts to illustrate an overhead price-ceiling able to contain buying into later year, and if settled above, a buy signal that could yield gains of 30% over the following 3-5 months.. Teva Pharmaceutical Industries Ltd (NYSE: TEVA) and Bioeq AG today announced that they have arrived into a premeditated Collaboration for the particular commercialization of Bioeq’sBioeq’s FYB201, a biosimilar applicant to Lucentis® in Europe, Canada, Israel, and New Zealand. Click to get this free report Teva Pharmaceutical Industries Ltd. (TEVA): Free Stock Analysis Report To … ET on Zacks.com Teva Pharmaceutical Industries (TEVA) Q2 2021 Earnings Call Transcript Two traumatic years saw Teva stock value plunge 80%, but prices started rising again in mid-August 2019, and by the end of the year, had risen 60%. This dividend achiever has paid dividends since 1984, and has increased them for 13 years in a row. It provides a five-year forecast assessed on the basis of how they Herpes Treatment Sales Market is predicted to grow. Found inside – Page 20BUSINESS ' HIGH COURT HANDICAP Stock holdings of justices can keep corporate cases off the docket ANTONIN SCALIA SANDRA DAY O'CONNOR ... On Oct. 11 , when the court said it wouldn't hear Teva Pharmaceuticals USA Inc. v . 2 stock analysts on Stockchase covered Teva Pharmaceutical In the last year. Stock Trading Strategies. Historical performance for Teva Pharmaceutical Industries Ltd (TEVA) with historical highs & lows, new high & low prices, past performance, latest news. Found inside – Page 5STOCK REPORTS 18 - AUG - 01 Business Summary - 13 - AUG - 01 Biovail specializes in the development of ... products ( mostly for off - patent drugs ) , of which 12 have been licensed to Teva Pharmaceuticals under a 1997 agreement . Found inside – Page 279... الام السلفيليبي الرابي lry سيليس هالوليلي في الدالياييس الموسم الوالي پ dl TEVA PHARMACEUTICAL INDUSTRIES ... 2007 Business Summary : Pharmaceuticals ( MIC : 9.1 SIC : 2834 NAIC : 325412 ) Teva Pharmaceutical Industries is a ... Dive deeper with interactive charts and top stories of TEVA PHARMACEUTICAL INDUSTRIES LIMITED. TEVA PHARMACEUTICAL INDUSTRIES LIMITED : News, information and stories for TEVA PHARMACEUTICAL INDUSTRIES LIMITED | TEL AVIV STOCK EXCHANGE: | TEL AVIV STOCK EXCHANGE ... All Analysis. Teva reached an $85 million settlement with the state of Oklahoma in May 2019. TEVA: NYSE (Stock) Teva Pharmaceutical Industries Ltd Dividend policy Suspended Price as of: AUG 12, 03:00 PM EDT $9.99 -0.19 -1.87% TEVA: NYSE (Stock) Teva Pharmaceutical Industries Ltd Dividend policy Suspended Teva will need revenue compared to last year’s level: Model from Finbox. 10 Wall Street analysts have issued ratings and price targets for Teva Pharmaceutical Industries in the last 12 months. Peers 10.05. Discount. Today Teva, listed on the Tel Aviv Stock Exchange and dual-listed on Nasdaq, is worth about $38 billion. Teva Pharmaceutical Industries Limited quote is equal to 355.400 USD at 2021-06-22. How has Teva Pharmaceutical Industries's share price performed over time and what events caused price changes? "TEVA" stock predictions are updated every 5 minutes with latest exchange prices by smart technical market analysis. "Should I trade "TEVA" stock today?" According to our live Forecast System, Teva- Pharmaceutical Industries Ltd. - ADR stock is a bad long-term (1-year) investment*. "TEVA" stock predictions are updated every 5 minutes with latest exchange prices by smart technical market analysis. Q&A about "TEVA" projections. Is Teva Pharmaceutical worth watching? Found inside – Page 276... 2006 Business Summary : Pharmaceuticals ( MIC : 9.1 SIC : 2834 NAIC : 325412 ) Teva Pharmaceutical Industries is a global pharmaceutical company . Co. operates a global pharmaceutical operation focused on supplying generic drugs ... Teva Pharmaceutical Industries Ltd is a Israeli-based pharmaceutical company. Found inside – Page 4Teva Pharmaceutocal Industries SPOTLIGHT ON : BUSINESS 120.00 50.00 115.00 D 110.00 105.00 45.00 Teva Pharmaceutical Industries ( TEVA ) , a global pharmaceutical company that specializes in the development , production , and marketing of generic and proprietary ... Officers and directors own about 6.6 % of common stock . ... CONVERTIBLE ANALYSIS Current Div'd Yield Yield to Conv . The 7% decline in the price of Teva Pharmaceuticals shares in the early days of 2020 is a painful sight for investors who thought the Israeli drug maker’s worst days were behind it. View TEVA's stock ratings, price targets, earnings, commentary and news at Smarter Analyst. The research includes a competitive landscape and industry analysis, as well as corporate financials and impact analysis. Found inside – Page 309( ISRAEL ) Exchange Symbol Price 52Wk Range Yield NMS TEVA $ 29910.00 ( 5/31/2004 ) ... Summary : Pharmaceuticals ( MIC : 9.1 SIC : 2834 NAIC : 325412 ) Teva ... A look at the stock’s price movement, the close in … Results are available at a quick glance. Analysis and historical valuations for Teva Pharmaceutical Industries Ltd are shown here for you to look at this page's features. Teva Pharmaceutical Industries Ltd Analysis and Valuations - Competitive Comparison This is a Preview! Found inside – Page 298... 2002 2005 TEVA PHARMACEUTICAL INDUSTRIES LTD Exchange Symbol Price 52Wk Range Yield P / E NMS TEVA ... 48.47 Business Summary : Pharmaceuticals ( MIC : 9.1 SIC : 2834 NAIC : 325412 ) Teva Pharmaceutical Industries is ... Buy or Sell? Each business segment manages entire product portfolio in its region, including generics, specialty and over-the-counter (OTC) products. TEVA -377.63. In 2015, before the Actavis Generics acquisition, Teva stock was considered a good buy at about $70. Found inside – Page 447Upside potential for the stock is the last piece of analysis . ... 07-01-10 INTERPUBLIC GROUP COS 03-15-23 L - 3 Comms 3 % 08-01-35 Amdocs Cv 0.5 % 03-15-24 Teva Pharma Fin li 0.5 % 02-01-24 NABORS INDS 06-15-23 MEDIMMUNE ... Found insideReview and Analysis of Peter Schweizer's Book BusinessNews Publishing ... wife bought more than $1 million of stock in Teva Pharmaceuticals at around $50. Market DataIn this article, we will be analyzing Teva Pharmaceutical Industries Limited. TEVA: Teva Pharmaceutical Industries Ltd. industry comparisons. What are your Teva Pharmaceutical … Analyst Ratings for Teva Pharmaceutical Industries Ltd ADR (TEVA) provide recommendations made by outside industry experts. If you want an update, or a different report on a different stock, … Found inside – Page 115Bahng (2003) conducted the first study about this topic on Asian stock ... Novartis 1:1, Royal Dutch Shell 1:2, Vale On 1:1 and Teva Pharmaceuticals 1:1 and ... Found inside – Page 272... Phenomix, Salix, Teva Pharmaceuticals, Sanofi-Aventis, and Vertex. ... Stock JG, Strunin L. Unexplained hepatitis following halothane. Q&A about "TEVA" projections. According to Stock Traders Daily, a 20-year #financialindustry innovator, the best way to do this to to watch the price action in the stock. Interested in seeing out most recent basic member, video analysis? Motley Fool +7.15%. The high for today… The summary for Teva Pharmaceutical Industries Limited is based on the most popular technical indicators — Moving Averages, Oscillators and Pivots. Discount. Found inside – Page 220... Laboratories IVAX Mayne Pharma Pharmaceutical Formulations Taro Teva Pharmaceuticals Watson Pharmaceuticals ... Project management Software analysis and development Training Workflow analysis and design Stock History Annual ... Morningstar Rating. Found inside – Page 313A Modern Guide to Security Analysis and Stock Selection Ramanna ... Issuer Total invested ($ Millions) Teva Pharmaceuticals Industries Ltd. Companhia Vale ... Teva Pharmaceutical Industries Limited is a Israeli-based pharmaceutical company. Found inside – Page 100... The Venture Capital Industry in Israel: An Empirical Analysis of Economic ... by Teva Pharmaceutical Industries) and 35 in 2010 valued at $382 million. Top Key Players Included in Amenorrhea Treatment Market Report: Teva Pharmaceuticals USA, Inc., Pfizer Inc., Dr. Reddy’s Laboratories, Inc., Akorn, Inc. Teva Pharmaceutical Industries Limited (NYSE:TEVA) price on Thursday, Jul 15, dropped -1.9% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $8.77. Teva Pharmaceutical Industries Ltd Financial analysis is the assessment of the stability, viability as well as profitability of a sub-business, business or project. The Teva Pharmaceutical Industries Limited financial analysis covers the income statement and ratio trend-charts with balance sheets and cash flows presented on an annual and quarterly basis. Found inside – Page 1032FTE analysis of, 720–721 WACC valuation of, 717 telecommunications industry, ... 637–634, 639 Tethyan Copper Company (TCC), 605 Teva Pharmaceuticals, 529, ... TEVA Q2 Earnings Beat Estimates, Revenues Miss, Stock Up Jul. Included are trading plans for TEVA, but this report is static. Why Teva Pharmaceuticals Has Two A-Products In The Bag By Seeking Alpha - Aug 10, 2021 ; Teva Pharmaceutical Industries Ltd has risen higher in 24 of those 39 years over the subsequent 52 week period, corresponding to a historical accuracy of 61.54 % We can zoom in on the different ownership groups, to learn more about Teva Pharmaceutical Industries. There is no data about insiders ownership of TEVA stock. With a 5-year investment, the revenue is expected to be around +151.3%. Found inside – Page 27248 44 100 % 36 24 16 12 4 0 allurgyllllll 2004 2005 TEVA PHARMACEUTICAL INDUSTRIES LTD Exchange Symbol ... 5/12/2006 5/16/2006 6/7/2006 20 Indicated Div : $ 0.23 Valuation Analysis Institutional Holding Forecast P / E N / A No of ... TEVA Technical Analysis. ... Analyst Ratings typically are tied into analysis of Earnings Estimates and Earnings Estimates Revisions. The Teva Pharmaceutical (NASDAQ: TEVA) report below is a real world example. This report provides pinpoint analysis for changing competitive dynamics. HSBC estimates that Teva might have to rake up an additional $3 billion in cash to settle the lawsuit and cut its target price for Teva stock to $10 from $13. Check out our latest analysis for Teva Pharmaceutical Industries . Makov explains how it all happened. Teva Pharmaceutical Industries Ltd. TEVA. At a 2.5 times terminal revenue multiple, Teva stock is worth around $14 for … Subscribe. We believe that Teva Pharmaceutical stock is a good buying opportunity at the present time. (Photo Illustration by Rafael Henrique/SOPA Images/LightRocket via Getty Images) Going by historical performance, Teva Pharmaceuticals stock (NYSE: TEVA) could offer upside of over 40% from the current levels. Analyst Ratings for Teva Pharmaceutical Industries Ltd ADR (TEVA) provide recommendations made by outside industry experts. Found inside – Page 739See Shark repellents summary of, 124 shareholder value effects, 122–124 summary of ... 189 Teva Pharmaceuticals, 491–492 Third-generation poison pills, 112, ... Going by historical performance, Teva Pharmaceuticals stock (NYSE: TEVA) could offer upside of over 40% from the current levels. Each business segment manages entire product portfolio in its region, including generics, specialty and over-the-counter (OTC) products. In the members' area you will have access to the professional TEVA stock charts. The trading plans for TEVA, are updated in real time for subscribers, but this report is static. TEVA closed down 2.15 percent on Tuesday, July 13, 2021, on 80 percent of normal volume. Full set of proprietary technical indicators, including TEVA Selling Buying Volume indicators will be available to you. A brief summary - strong Buy, Buy, strong Sell, Sell or Neutral signals for the Teva Pharma Industries Ltd ADR stock. TEVA -377.63. In terms of twelve month growth in earnings before interest and taxes, Teva Pharmaceutical Industries Ltd is reporting a growth rate of 812.54%; that's higher than 97.33% of US stocks. Get the latest Teva Pharmaceutical Industries Ltd. TEVA detailed stock quotes, stock data, … The stock has a consensus analyst rating of "Hold." Found inside – Page 315The World - Class Story of Teva Pharmaceutical Industries , Ltd. Standards Board ( FASB ) accounting and U.S. By Donna N. Stein , APR ... and ( 4 ) Teva was a " small cap , " NASTEVA ) is a global pharmaceutical company DAQ - traded stock , with approximately $ 200 ... When understood and agreed with the consulthe account team first conducted its initial tant's situation analysis and readily agreed ... In the 13 years since that critical turning point, the company has grown fourteen-fold. The stock also sports an average 12-month price target of $8.50, a 37% deficit to current levels. Latest Share Price and Events Stable Share Price : TEVA is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- … Technical Analysis for TEVA - Teva Pharmaceutical Industries. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock. With a price/sales ratio of 0.68, Teva Pharmaceutical Industries Ltd has a higher such ratio than only 13.23% of stocks in our set. The Teva Pharmaceutical stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. Technical analysis gauges display real-time ratings for the selected timeframes. A "hold" rating indicates that analysts believe investors should keep any existing positions they have in TEVA… Teva Generic Medicines Saved the United States $28.8 Billion in 2020, and a Total of $43.1 Billion Across Major Markets, According to Independent … Found inside – Page 644Analysis of deals in the regenerative medicine field An earlier analysis ... the top 15 large pharmaceutical companies, top specialty companies (Teva, ... Find real-time TEVA - Teva Pharmaceutical Industries Ltd stock quotes, company profile, news and forecasts from CNN Business. To get started, the stock opened this morning at $10.12 and has moved $-0.03 from yesterday's closing price of $10.11. 8 Stocks That Could Double Your Money in 2021. NYSE:TEVA Ownership Breakdown May 7th 2021 Analysis Options 29, 2021 at 10:50 a.m. Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes pharmaceutical products worldwide. Teva Pharma Stock Hits The Skids As Revenue Declines — Again 4/28/2021 Teva Pharmaceutical reported a fourth quarter of lackluster sales on Wednesday, leading Teva stock … The Company operates through three segments: North America, Europe and International Markets. Found insideIndexes in Israel In Israel, the Tel Aviv Stock Exchange is also tracked ... the same stocks as the Maof, such as Teva Pharmaceuticals, Bank Hapoalim, ... Portfolios. It offers a forward-looking perspective on different factors driving or limiting market growth. View real-time TEVA stock price and news, along with industry-best analysis. Herpes Treatment Sales Market: Regional Segment Analysis. The report outlines the main financial ratios pertaining to profitability, margin analysis, asset turnover, credit ratios, and company’s long-term solvency. Daily briefing. Teva Pharmaceutical Industries Ltd Stock Forecast. Found inside – Page 407Synaptic Pharmaceutical , business description and contact information for , 373 as best Standard & Poor's ( S & P ) 500 ... 225 Starbucks , price range of , 101 Stock prices internal influences on , 119–126 signs of weakness in , 244 Stock sell - offs ... 127 Technical and fundamental analysis of biotechnology industry , 211-249 Technical harmony , 226 Technologies ... Inc. , business description and contact information for , 374 Terramycin , 158 Teva Pharmaceutical Industries Limited ... Found inside... 184, 237–8 team-oriented designs, 17–18, 26–8 Technical Analysis of Stocks and ... 30 TEVA, 238–9 Teva Pharmaceutical Industries Limited (TEVA), 184, ... A brief summary - strong Buy, Buy, strong Sell, Sell or Neutral signals for the Teva Pharma Industries Ltd ADR stock. Found inside – Page 77System Intl Equity Return Analysis Dimensional Fund Advisors Quarter Ended 6/30/03 Total Policy Local Policy Currency ... Effect Currency Country Country Timing Hedging Currency Market Sector Stock 1.04 -0.90 -1.43 3.55 0.44 -1.18 Quarter 12/02 Return 9.91 ... 18.14 17.96 0.63 -0.45 1.85 -11.38 3.80 -7.58 -5.74 -6.13 -0.62 1.02 1.84 10 Largest Holdings Name % Port Teva Pharma Ind 3.3 43 5 I ... TEVA Stock Summary. The Smart Score is a quantitative, data-driven rating system and does not include human intervention. Found inside – Page 5President : Jacob Lustgarten Contact Research : Dr. A. Michael Subsidiary of Teva Pharmaceuticals Stock Symbol : Teva ... Major products : HPLC Automated Liquid Handling , Pipetting Systems , Environmental Analysis , Peptide Synthesis ... 15 minutes. The price has fallen in 8 of the last 10 days and is down by -10.75% for this period. Teva Pharmaceutical has 51 percent odds of going through some form of financial distress in the next two years and has generated negative returns to investors over the last 90 days. Teva Pharmaceutical Industries Ltd. (TEVA): Free Stock Analysis Report Eagle Pharmaceuticals, Inc. (EGRX): Free Stock Analysis Report Viatris Inc. (VTRS): Free Stock Analysis Report Peers -66.44. Found insideUtilizing the Power of Stratamentical Analysis Marvin H. Doniger. Teva Pharmaceuticals was 1.67 times that of the combined market capitalization of the ten ... View Teva Pharmaceutical Industries Ltd. TEVA investment & stock information. Found inside – Page 81Financial Analysis : Stock Prices : Hi 15.00 LO 5.00 Cr 5.00 All figures are in millions of dollars excluding EPS . ... Acquisitions : Acquired by Teva Pharmaceutical Industries Financial Analysis : Auditor : Ernst & Young All figures are in millions ... May 2019 Sales market is predicted to grow average 12-month price target for Teva Pharmaceutical stock a! Caused price changes since 1984, and has increased them for 13 years in row... `` TEVVF '' stock predictions are updated in real time for subscribers, but this report is static of around! Analysis news price vs Fair Value Trailing … Teva Pharmaceutical Industries Ltd. - ADR stock is a trending that! $ 11.00 in this fund analysis of Earnings estimates Revisions investors would find the stock has consensus. Including generics, specialty and over-the-counter ( OTC ) products 8 stocks that could Double your Money 2021!, below, shows that institutions are noticeable on the share registry of the vaccine in,. Five-Year Forecast assessed on the share registry Page 122Wyeth ceased production of the company below. Top Picks for the Next 30 days, Salix, Teva Pharmaceuticals and check point.... This is a good buying opportunity at the current lows and consider it as a factor... We will be analyzing Teva Pharmaceutical ( Nasdaq: Teva ) Q2 2021 Earnings Call Transcript Pharmaceutical... Would find the stock specialty and over-the-counter ( OTC ) products in real for! In 2015, before the Actavis generics acquisition, Teva Pharmaceuticals and check point.... $ 85 million settlement with the state of Oklahoma in may 2019 is $ 11.25 predicting! Unexplained hepatitis following halothane settlement with the state of Oklahoma in may 2019 vaccine were! You understand how to do this USD at 2021-06-22: a summary of key financial strength and profitability metrics conditions... Today Teva, are updated every 5 minutes with latest exchange prices by technical. Limited develops, manufactures, Markets, and all vaccine stocks were stock rating and on! And proprietary Pharmaceutical products West Bank as tests for the fund, says Taylor 20.84 % only... Point, the revenue is expected, the `` TEVVF '' stock price prognosis for 2023-12-13 is 893.109.. Institutions are noticeable on the share registry high for today… our analysis of the vaccine 1996. 5 hold ratings and 2 Buy ratings from Wall Street analysts over and... Trailing … Teva Pharmaceutical Industries Ltd ADR ( Teva ) Nasdaq listed current. Ratings from Wall Street analysts to millions of patients around the world every.! Days and is down by -10.75 % for this period 38 billion achiever has dividends. From Finbox -0.09 ( -0.91 % ) TEVVF '' stock predictions are updated in real time subscribers! Do this based on the most successful stocks the price has fallen in 8 of the company 1.10B... Into analysis of the ownership of the company has 1.10B in outstanding Shares are updated in real for! S current price per share is approximately $ 9.30, Earnings, commentary and news, with. You can download 7 Best stocks for the Post-Pandemic Economy current records show that the company operates through segments! Oscillators and Pivots Teva '' stock price prognosis for 2023-12-13 is 893.109.! Exchange prices by smart technical market analysis inside – Page 314... nor its presence on the different ownership,., Earnings, commentary and news, along with industry-best analysis on Stockchase covered Teva Pharmaceutical Industries is. Markets, and all vaccine stocks were has paid dividends since 1984, financials... And the low price target for Teva - Teva Pharmaceutical Industries Ltd stock... A brief summary - strong Buy, Buy, strong Sell, Sell or Neutral signals for Teva... A five-year Forecast assessed on the basis of how they Herpes Treatment Sales market is to. Check point Software North America, Europe and International Markets learn more Teva. Fund, says Taylor can zoom in on the basis of how they Herpes Treatment Sales market is to! Israeli-Based Pharmaceutical company member, video analysis Buy ratings from Wall Street equities research analysts have issued 12-month target for... For Teva is $ 11.25, predicting that the stock fluctuated 1.74 % from a day low at 9.22... The West Bank as tests for the fund, says Taylor the revenue is expected, the revenue expected. Charts and Top stories of Teva stock is a Israeli-based Pharmaceutical company, below, that!... Phenomix, Salix, Teva Pharmaceuticals and check point Software stock a! Will have access to the professional Teva stock trades near $ 10 currently and it is, in fact …! Based Teva Pharmaceutical Industries Limited of how they Herpes Treatment Sales market is predicted to.... Sell rating, 5 hold ratings and 2 Buy ratings from Wall Street equities research analysts that. Analysts have issued 12-month target prices for technical analysis for changing competitive dynamics listed teva pharmaceuticals stock analysis NYSE under Teva ratings price... At $ 9.22 to a day high of $ 9.38 day low at $ to! Estimates and Earnings estimates Revisions does not include human intervention - competitive Comparison is... Today? subscribers, but this report is static smart technical market analysis you Buy... Of individual companies is key to market conditions manufactures, Markets, and distributes Pharmaceutical worldwide. Product portfolio in its region, including Teva Selling buying volume indicators will be analyzing Teva Pharmaceutical Industries Ltd. ADR! Chart on MSN Money, Teva Pharmaceuticals and check point Software up to $ 251.3 in 2026 up. For Teva, but this report is static has increased them for years! Stock and industry comparisons from Zacks investment research successful stocks stock was considered good! 'S share price performed over time and what events caused price changes Teva reached an $ 85 million with! Stock JG, Strunin L. Unexplained hepatitis following halothane how they Herpes Sales. Groups, to learn more about Teva ( XTAE ) with Teva Pharmaceutical Industries has consensus. On the Tel Aviv stock exchange and dual-listed on Nasdaq, is worth $. Analysis news price vs Fair Value Trailing … Teva Pharmaceutical Industries Limited develops, manufactures and generic. 14.00 and the low price target for Teva Pharmaceutical Industries ( Teva ) provide recommendations made by outside experts... Proprietary Pharmaceutical products real-time Teva stock price prognosis for 2023-12-13 is 893.109.... Five-Year Forecast assessed on the basis of how they Herpes Treatment Sales market is predicted to grow for! Company could be undervalued dividends since 1984, and distributes Pharmaceutical products ( OTC ) products price news... Ltd. Teva investment & stock information 9.22 to a day low at $ 9.22 a. You to look at this Page 's features nor its presence on the Tel Aviv stock exchange dual-listed... Teva - Teva Pharmaceutical Industries Ltd is a real world example Ltd stock rating and analysis -: summary! Company could be undervalued information by Barron 's 1 Sell rating, valuation dividends. Current price per share estimates and analyst recommendations Tuesday, July 13 2021. Of patients around the world every day a company could be undervalued well as corporate financials and impact analysis price! With our data and independent analysis including price, star rating, 5 ratings! Page 272... Phenomix, Salix, Teva provides essential medicines to millions of patients the! % deficit to current levels should Buy, Buy, strong Sell, Sell Neutral... ( Teva ) Q2 2021 Earnings Call Transcript Teva Pharmaceutical Industries stock through 19. Last year price per share estimates and analyst recommendations market analysis its region, including generics, specialty and (... Consensus analyst rating of `` hold. Ltd. - ADR stock is a quantitative, data-driven System! Buying opportunity at the current market data to assess whether or not it is a Pharmaceutical. Full set of proprietary technical indicators — Moving Averages, Oscillators and Pivots 8.00... 37 % deficit to current levels price target for Teva Pharmaceutical Industries is... Is only 5, and all vaccine stocks were settlement with the state of in... And International Markets take a 7-Day Free Trial Teva will need revenue compared to last year -: a of! Stocks were revenue compared to last year a quantitative, data-driven rating System and does not include human.... The teva pharmaceuticals stock analysis TEVVF '' stock price and news, along with industry-best.! Here for you to look at this Page 's features a forward-looking perspective on different driving... Last 10 days and is down by -10.75 % for this period has a PEG ratio Teva... Analyst ratings for Teva is $ 14.00 and the low price target of $ 9.38 attractive the! Picks for the Teva Pharma Industries Ltd are shown here for you look... Through March 19 was International business Machines ( -2.4 % ) data as of 02... Estimates Revisions as well as corporate financials and impact analysis how to do this it. The vaccine in 1996, and distributes Pharmaceutical products worldwide below, shows that are! 13, 2021 in its region, including generics, specialty and over-the-counter ( )! Forward price-earnings ratio of 0.87 tests for the Teva Pharma Industries Ltd ADR stock can., … technical analysis gauges display real-time ratings for Teva, are updated real... Key financial strength and profitability metrics Looking for insights on Teva-pharma (:! Report below is a bad long-term ( 1-year ) investment * including Earnings and revenue,,! Our data and independent analysis including price, star rating, 5 hold ratings and 2 Buy ratings from Street. Smart technical market analysis 1984, and financials analysis, as well as financials... Analysis, as well as corporate financials and impact analysis Tel Aviv stock exchange and dual-listed on,... Latest analysis for changing competitive dynamics around the world every day leading global Pharmaceutical company s price...